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ABSTRACT 
P. gingivalis, a red complex bacterium, has been associated with periodontitis. It has been 
studied extensively trying to understand the mechanism behind its virulence against the 
periodontium. Several investigations have studied the different virulence factors including 
Lipopolysaccharide (LPS), gingipain and fembriea. However, bone resorption mechanism that is 
caused by periodontitis is not fully understood. It is hypothesized that P. gingivalis virulence 
factors specifically LPS are behind bone resorption, not the bacterial cell itself. Therefore, we 
have tested this hypothesis and then further expanded on the results by adding Kavain that inhibit 
LPS-induced TNF-α in an attempt to rule out other virulence factor from bone resorption 
mechanism.  
Live neonatal mouse calvarial bone was utilized to carry out experiments in this project. 
We had five groups which included negative and positive control with parathyroid hormone 
(PTH) and PTH with Kavain and test groups with P. gingivalis supernatant with or without 
Kavain. These model systems were tested under resorption condition and evaluated by chemical, 
biochemical and histological analyses of the used media and calvarial bone. At the 8th day, 
calvaria from each experiments were analyzed by histology. TRAP and calcium release assays 
were also performed to further evaluate bone resorption and osteoclastic activity.  
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We have found that when Kavain was added to the PTH, the calcium release and TRAP 
activity has reduced to half of the positive control without Kavain. P gingivalis supernatant alone 
showed uptake of calcium rather than release and adding Kavain increased the calcium uptake 
even more. However, TRAP activity were much higher than PTH group which does not coincide 
with the calcium release assay results.  
It seems that P. gingivalis LPS stimulated osteoclastic activity however it was not enough 
to result in bone resorption. It is thought that resorption and formation might be balanced and 
thus resorption was not observed. Further investigation is needed to study different doses of P. 
gingivalis supernatant on bone.  
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1. Periodontium 
The periodontium is composed of four essential components including: gingiva, periodontal 
ligaments, cementum and alveolar bone.  
1.1. Gingiva:  
Gingiva is a part of the oral mucosa termed masticatory mucosa that covers the alveolar 
process and tooth root to its cementoenamel junction. Anatomically it consists of three parts; 
marginal, attached and interdental gingiva. Marginal gingiva is also called unattached gingiva 
and is coral pink in color and surrounds the tooth in a collarlike fashion. Attached gingiva is 
tightly adherent to the underlying alveolar bone and has surface depressions called stippling. It is 
separated from the free marginal gingiva by a linear surface depression called the free gingival 
groove. It extends to the alveolar mucosa which lacks attachment to bone and is demarcated by 
the mucogingival junction. The last part of the gingiva is the interdental papilla that occupies the 
gingival embrasures. Its shape depends on many factors including: contact point locations on the 
adjacent teeth, the distance of the contact point of bone from the bony crest and the presence or 
absence of recession.  
1.2. Periodontal Ligaments (PDL) 
The PDL is a highly vascular and cellular connective tissue surrounding the tooth roots that 
connects the cementum and alveolar bone proper and forms the inner socket wall. It consists of 
five main fiber groups and many types of cells.  
1.2.1. Periodontal Fibers  
1.2.1.1. The alveolar crest fibers run from the cementum beneath the 
cementoenamel junction to the alveolar crest. 
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1.2.1.2. Horizontal fibers run from the cementum to the bone apical to the 
alveolar crest and are arranged perpendicular to the bone. 
1.2.1.3. Oblique fibers run from the cementum to alveolar bone in an outward and 
coronal direction. It is the most abundant type among the fibers groups. 
1.2.1.4. Apical fibers run from the cementum to apical bone in a radial fashion. 
1.2.1.5. Interradicular fibers run from the cementum to septal bone. 
1.2.2. Cells 
There are several types of cells occupying the periodontal ligament space. Fibroblasts are 
located along the PDL fibers, cementoblasts line the cementum, osteoblasts line the bone surface 
and some immune cells are also present. In addition, the epithelial rest of Mallassez which are 
remnants of Hertwig’s epithelial root sheath lies near the cementum.  
1.3. Cementum  
Cementum is an avascular specialized mineralized tissue covering the outer anatomical 
surface of the tooth root. It is deposited throughout life as part of the reparative process that 
mostly occurs at the apical part of the root. It is divided into acellular and cellular types. The 
acellular type is formed early before tooth eruption and is found in the cervical part of the root.  
Cellular cementum contains osteocytes in lacunae connected through canaliculi. It is further 
classified based on cellular and fibrillar components found in different region of the root 
cementum. Acellular afibrillar cementum lacks cells and fibers and is found in the coronal 
cementum. Acellular extrinsic fiber cementum has no cells but has Sharpey’s fibers which are 
the terminal part of the PDL fibers that are embedded into the cementum. Cellular mixed fibers 
cementum that contains cells and a mix of intrinsic and extrinsic fibers. Cellular intrinsic fiber 
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cementum containing cells and intrinsic fibers only (Bosshardt and Schroeder 1990, Bosshardt 
and Schroeder 1991, Bosshardt and Schroeder 1992, Nanci and Bosshardt 2006).  
1.4. Alveolar Bone Process 
This process forms and supports the sockets of both the maxilla and mandible. It is composed 
of an outer layer of very dense cortical bone and an inner cancellous bone that occupies the space 
between the two outer cortical bone layers and contains bone marrow. However, the lining of the 
socket is called alveolar bone proper and faces the PDL space. Cellular components include 
osteoblasts, osteoclasts and osteocytes.  
1.5. Function of PDL 
The PDL functions as a shock absorber through distribution of the occlusal load to bone, it 
attaches the tooth to the bone and functions in maintenance of gingival tissue.  
There are many diseases that affect the periodontium leading into bone loss. In order to 
understand the pathogenesis, it is necessary to understand basic bone biology first.  
 
2. Bone Biology  
2.1. Bone Structure  
Bone is a mineralized connective tissue composed of compact and trabecular bone. Compact 
bone is a dense outer layer whereas trabecular bone is less dense and forms a network that 
houses the red or yellow marrow filled medullary cavity.  
At the microscopic level, compact bone contains three main lamellae; the circumferential, 
concentric and interstitial. The circumferential lamellae form the outer and inner perimeters 
while most of the bone body is formed of concentric lamellae containing the bone basic 
metabolic unit, the Haversian system. Each Haversian system is composed of a Haversian canal 
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that contains capillaries and nerves and runs along the long axes of the bone. Volkmann canals 
are channels that connect the adjacent Haversian system and they also contain blood vessels. 
Finally, the interstitial lamellae fill the spaces between the concentric layers. 
The periosteum is a two-layer connective tissue membrane that covers the outer aspect of 
compact bone. The outer fibrous layer is dense connective tissue while the inner layer is rich in 
small blood vessels and bone cells including the osteoprogenitor cells. The inner surface of 
compact and cancellous bone is covered by the endosteum which is a layer of loose connective 
tissue containing mainly osteogenic cells.   
Bone provides important protection to the underlying vital structures in addition to support 
and mineral reservoir and is an important source of blood cells and stem cells.  
2.2. Bone Composition  
2.2.1. Extracellular Composition 
The extracellular matrix of the bone consists of 30% organic and 70% inorganic 
components. The organic matrix is 90%-95% type I collagen and 5-10% non-collagenous 
proteins (Nanci 2008) and ground substances (Hall and Guyton 2005). The non-collagenous 
proteins include bone sialoproteins, osteonectin, osteocalcin and osteopontin (Nanci 2008). The 
ground substances contains proteoglycans such as hyalouronic acid and chondroitin sulfate (Hall 
and Guyton 2005).  
The Inorganic component of the bone is mineral salts of calcium and phosphate in the 
form of hydroxyapatite crystals with a chemical formula of Ca10(PO4)6(OH)2. Several other 
minerals can be found as a part of the inorganic components such as magnesium, carbonate, 
potassium and sodium. This unique structure of the bone gives it the ability to resist compressive 
stresses via the hydroxyapatite crystals whereas type I collagen provides tensile strength.  
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2.2.2. Cellular Composition 
2.2.2.1. Osteoblasts  
Osteoblasts are cuboidal or slightly flattened cells with a single nucleus. They are derived 
from ectomesenchyme in the head and from the mesenchyme for the rest of the body (Nanci 
2008). Since these cells are responsible for production of bone matrix they contain organelles 
that are important for protein synthesis. They secrete type I collagen as well as type V collagen 
and some ground substances. Alkaline phosphatase is an important enzyme involved in bone 
formation. It occurs on the surface of the osteoblast plasma membrane when the cells are actively 
depositing bone matrix. After the synthesis of type I procollagen intracellularly it is secreted 
from the cells to be assembled and matured forming fibrils extracellularly. The uncalcified 
matrix composed of those accumulated fibrils is called osteoid that will be mineralized. 
Noncollagenous proteins occur in the osteoid and have a role in mineral deposition.  Osteoblast 
not only form the bone matrix but also secretes growth factors and cytokines that regulate bone 
formation. Those secreted growth factors include Transforming growth factor β (TGF-β), 
platelet-derived growth factor (PDGF), and insulin-like growth factor (IGF-I and IGF-II) which 
are members of the bone morphogenic protein (BMP) superfamily.  
Once bone is formed, those cells become less active and start to change shape to more 
flat cells with less organelles. They are connected by gap junction to allow communication and 
network that will help regulate mineral homeostasis.  
2.2.2.2. Osteocytes 
As the bone matures, the osteoblasts become embedded in the bone in a lacuna and 
become osteocytes. They become stellate-shaped cells with cytoplasmic processes that are 
embedded in canaliculi. Those cytoplasmic extensions enable the osteocytes to communicate 
6 
	
with other surrounding bone cells such as osteoblasts and bone surface cells. With this 
communication osteocytes are able to sense the biochemical and mechanical changes in the 
surrounding environment and respond to those changes through signaling systems and translation 
of those changes in loading into chemical signaling (Lindhe, Lang et al. 2008, Nanci 2008).  
2.2.2.3. Osteoclasts  
Osteoclasts originate from hemopoietic stem cells through fusion of monocytes and 
macrophages that lead to formation of multinucleated cells. They are responsible for bone 
resorption. They are characterized by the Tartrate-resistant acid phosphatase (TRAP) enzyme 
that reflects the activity of the osteoclasts and differentiate them from the multinucleated giant 
cells. In the resorption process they adhere to the bone surface and produce acid and lytic 
enzymes that dissolve matrix and mineral and results in formation of cavities known as 
Howship’s Lacuna (Lindhe, Lang et al. 2008, Nanci 2008).  
2.3. Mechanism of Bone Formation  
Bone formation occurs by either intramembranous ossification or endochondral ossification. 
Intramembranous ossification is characterized by direct bone formation from mesenchyme 
whereas endochondral ossification replaces an existing cartilage with bone. The former process 
occurs in cranial vault, maxilla and body of the mandible. Endochondral formation occurs in all 
long bones, vertebrae, ribs and base of the skull.  
In intramembranous bone formation, osteoblasts differentiate from mesenchymal stem cells 
and proliferate and deposit bone matrix which later become mineralized.  
During endochondral bone formation chondroblasts differentiate from mesenchymal stem 
cells and produce a cartilage matrix containing collagen type II and X. This formed cartilage acts 
as a scaffold for future bone formation. This take place first in the midshaft of the diaphysis 
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where vascularization increases and osteoblasts differentiate. This leads to converting 
perichondrium into periosteum through intramembranous ossification. In the middle of the 
cartilage chondroclasts resorb the cartilage matrix creating room for differentiated osteoblast to 
develop and proliferate forming new bone in the place of previous cartilage matrix. As the bone 
matures and the bone become longer, the core mineralized cartilage resorbs through osteoclastic 
activity allowing expansion of bone marrow cavity.  
Secondary ossification centers occur in the epiphysis of the long bone that result in formation 
of the epiphyseal growth plate. Longitudinal bone growth occurs through chondrocyte cell 
division and interstitial growth in the epiphyseal plate. Once chondroblasts stop proliferating and 
the growth plate disappears, bone formation stops (Nanci 2008).  
2.4. Mechanism of Bone Resorption  
Bone resorption starts by creating a sealed microenvironment between osteoclasts and the 
bone surface through cytoplasmic processes at the periphery that are devoid of organelles. Bone 
sialoprotein and osteopontin facilitate osteoclast adhesion and formation of the sealing zone. 
Through the action of proton pump the sealed environment becomes more acidic causing 
demineralization of bone and exposure of the organic matrix. Degradation of the organic matrix 
occurs through secreted enzymes such as acid phosphate and cathapsin B. The products of 
degradation are endocytosed through the ruffled border of the osteoclasts. These products 
undergo transcytosis into the extracellular fluid through vesicles along the membrane opposite to 
the ruffled border (Franzen and Heinegard 1985, Nanci 2008, Zou and Teitelbaum 2010).  
2.5. Modulation of Bone Resorption  
Bone resorption is facilitated through signaling pathways involving the receptor-activated 
nuclear factor kappa-B (RANK) and its ligand (RANKL). Those signals play a major role in the 
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differentiation of osteoclasts. The bone formation/ resorption coupling process can shift toward 
more resorption when osteoblasts expose RANKL to osteoclast precursor cells via interacting 
with the RANK receptor expressed on their surfaces and stimulate formation of mature 
osteoclasts. However, this process can be inhibited by osteoprotegerin (OPG). This process is 
regulated by calcium signaling (Sims and Gooi 2008). Blood calcium homeostasis is tightly 
regulated by many hormones including: parathyroid hormone, vitamin D and calcitonin in 
addition to thyroid hormone, sex hormones and retinoic acid (Lindhe, Lang et al. 2008) .When 
blood calcium drops, parathyroid hormone (PTH) is secreted leading to release of calcium from 
bone and decreased calcium excretion from kidney. It also activates the 1-σ-hydroxylase that 
produces calcitriol which increases absorption of calcium from the intestine. Calcitonin secretion 
from the thyroid gland is stimulated when blood calcium is elevated. It interferes with formation 
of osteoclasts and bone resorption (McCauley and Nohutcu 2002). 
2.6. Bone Modeling and Remodeling  
Bone modeling is a process that occurs during bone development and growth from 
embryonic development to the pre-adult period of human growth to establish the final shape and 
size of the bone. During this period bone formation exceeds bone resorption which is necessary 
for bone growth and increase in thickness and length. The coupled bone formation/ resorption 
process occurs simultaneously where formation occurs on the periosteal bone surface whereas 
resorption takes place on the endosteal surface leading to changes in the shape of the bone.  
Bone remodeling is a process by which old bone is replaced by new bone without changes in 
the shape of the bone. This process continues throughout life through the coupled controlled 
activity of osteoblasts and osteoclasts. Under normal condition bone formation equals bone 
resorption without net loss of overall bone volume. In some diseases bone resorption exceeds 
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formation which results in loss of bone. Remodeling five basic stages include: activation, 
resorption, reversal, formation and resting. Osteoclastic activity and bone resorption precedes 
osteoblastic activity and bone formation. It is regulated through the RANK/RANKL and OPG 
signaling pathway (Nanci 2008).  
 
3. Periodontitis 
3.1. Definition  
Periodontitis is defined as “Inflammation of the periodontal tissues resulting in clinical 
attachment loss, alveolar bone loss, and periodontal pocketing” (Glossary of periodontal term 
2001) 
3.2. Epidemiology  
Eke and co-workers (2015) combined data from the National Health and Nutrition 
Examination survey (NHANES) of the 2009 to 2010 and 2011 to 2012 cycles to describe the 
prevalence, severity and the extent of periodontitis in the US adult population. Data of dentate 
adults from the US civilian non-institutionalized population aged ≥30 years was included. 
Probing depth and attachment loss from six sites per tooth of all teeth except third molars were 
used to define periodontitis. Among the adult US population overall prevalence of periodontitis 
was 46% of which 8.9% were severe periodontitis. The highest prevalence of periodontitis was 
found among Hispanics (63.5%) and non-Hispanic blacks (59.1%). Prevalence in non-Hispanic 
Asian Americans was 50.0% and the lowest prevalence was in non-Hispanic whites (40.8%) 
(Eke, Dye et al. 2015) 
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3.3. Etiological Factor 
The primary etiological factor of periodontal disease is “Bacterial plaque and its byproducts 
in a susceptible host”. 
3.4. Criteria for Determination of a Periodontal Pathogen  
Over the years those criteria have evolved. First, Koch postulated that microorganism must 
meet certain criteria to be identified as the causative agent of disease. First, the organism must be 
increased in case of the disease but be absent in healthy individuals. Second, after isolation of the 
organism and growth in pure culture the organism must have the ability to induce disease in 
healthy hosts. Third, they must be identical to the original causative agents when re-isolated from 
the diseased experimental animals. Although those criteria are beneficial some bacteria found in 
disease sites are also found in healthy ones. Periodontal disease is composed of a complex mix of 
microorganisms. Isolation of one specific microorganism that cause the disease is difficult.  
Socransky et al (1979) developed alternative criteria. First, the suspected pathogen should be 
increased in the disease more often than healthy sites. Second, when therapy is provided, the 
disease progression should be arrested or eliminated. Third, the suspected pathogen should 
induce host immune responses cause disease in animals (animal pathogenicity) and demonstrate 
features of periodontal disease. Fourth, the pathogen should have virulence factors that elicit 
inflammatory and immune responses resulting in periodontal tissue destruction (Socransky 
1979). Socransky and Haffajee (1992) refined those criteria and required that the causative agent 
must be a pathogenic strain which they named as virulent clonal type, it must have the genetic 
components necessary to start the disease process. It should occur in susceptible hosts and 
susceptible locations within the host and exists in sufficient quantity to overcome host defenses. 
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The presence of other microorganisms should not stop the disease and the pathogen should be in 
an environment that allows the virulence factor to be expressed (Socransky and Haffajee 1992).  
3.5. Microbiome and Dysbiosis  
Several studies have attempted to identify the complex bacterial species associated with 
periodontal disease. However, before discussing those investigations, it is important to 
understand the current periodontal disease pathogenesis and the biology behind it. 
Mucosal surfaces are colonized by many microorganisms that are in balance with the host. 
This balance is important for maintenance of good human health (Lindhe, Lang et al. 2008). 
Round and Mazmanian (2009) found that beneficial bacteria are lost as well as increased growth 
of potentially pathogenic bacteria can occur as a result of any disturbance in this microbiota 
ecological balance (Round and Mazmanian 2009). In 2010 the term dysbiosis described the 
unfavorable disturbance and changes in the composition of the microbiota (Hill and Artis 2010). 
A potential effect on health was suggested as a result of this symbiosis of normally balanced 
microbiota (Frank, Zhu et al. 2011). This concept was also found to hold true in terms of 
periodontal diseases resulting from an imbalance between host and the commensal microbiota 
(Lindhe, Lang et al. 2008).  
3.6. Periodontal Disease Hypothesis 
Several hypotheses have been developed to explain the main etiological factor of periodontal 
disease and the role of bacteria in its pathogeneses. Loesche (1976) introduced the specific 
plaque hypothesis suggesting that specific bacteria are pathogenic and are associated with the 
etiology of caries and periodontal disease regardless of the multiple complex mix of bacteria 
available in periodontal pocket (Loesche 1976). Species identified in the etiology of periodontal 
disease include P. gingivalis, P. intermedia, C. rectus, T. forsynthia, and T. denticola (Socransky 
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and Haffajee 1992). However, as the profound effect on the elimination of plaque on treatment 
and prevention of periodontal disease was observed, the non-specific plaque hypothesis was 
developed stating that in periodontal disease all bacteria present possess virulence factors that 
have the potential to initiate inflammation (Theilade 1986, Socransky and Haffajee 1994). These   
plaque bacteria are all pathogenic despite the diversity of strains. Plaque control was considered 
to be an effective way to eliminate and control the growth of bacteria (Theilade 1986, Loesche 
1992). However, this hypothesis failed to explain instances in which the presence of dental 
plaque failed to produce disease. Advances in microbiological testing allowed further 
investigation of bacterial specificity in periodontal disease and demonstrated association between 
certain bacteria and disease sites (Lindhe, Lang et al. 2008). This had led to more focus on the 
specific plaque hypothesis. Since specific bacteria were found to be associated with periodontal 
disease they were targeted for treatment.  It was also questioned whether those bacteria where 
acquired from the environment or from the available microbial flora  (Lindhe, Lang et al. 2008). 
With this issue being raised the ecological plaque hypothesis was introduced which claimed that 
interactions between bacteria in the biofilm determines the disease development rather than just 
the presence of certain bacteria in the biofilm bacteria complex (Marsh 1991, Marsh 1994). This 
hypothesis explains environmental factors such as PH, oxygen contents, Heme availability and 
the availability of different nutrients in the control of colonization of pathogenic bacteria in 
periodontal diseases (Lindhe, Lang et al. 2008). This again emphasizes the dysbiosis concept and 
its relation to periodontal diseases. 
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3.7. Microbial Complexes Associated with Periodontium in Health and in Disease  
3.7.1. Health  
Many studies have reported a positive association between periodontal heath and 
presence of certain bacterial species. Gram positive actinomycetes and streptococcus species 
predominate in healthy sites (Tanner, Maiden et al. 1998). Ximenez-fyvie et al (2000) confirmed 
the results of the previous studies and found that both supra- and sub-gingival plaque was 
predominantly colonized by actinomycetes species in healthy and periodontitis cases (Ximenez-
Fyvie, Haffajee et al. 2000). Traces of periodontal pathogens were found in healthy sites. 
Beneficial bacteria including S. Sanguis, Veillonella spp, and C. ochraceous were numerous in 
healthy sites (Socransky and Haffajee 1992, Ledder, Gilbert et al. 2007). 
3.7.2. Microbial Shift from Health to Disease  
The microbial shift refers to the changes in the composition and the number of the 
bacterial colonization as the disease develops. March (1994) found a microbial shift from gram 
positive aerobes to gram-negative anaerobes as the tissue changes from healthy to disease 
whether gingivitis or periodontitis (Marsh 1994). Comparison of cocci, spirochetes and motile 
microorganisms composition in samples of healthy and diseases plaque demonstrated non-motile 
microorganisms were drastically reduced as the tissue shifted from health to disease (Listgarten 
and Hellden 1978). 
3.7.3. Gingivitis  
In 1965 Loe and co-workers introduced the experimental gingivitis model. In these 
studies, the participants refrained from oral hygiene measures until they developed gingivitis. 
Three subjects out of 12 developed gingivitis at 10 days whereas the rest developed gingivitis in 
about 15 to 21 days. This concluded that individuals have different disease susceptibility and 
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different progression of the disease. They also investigated patterns of microorganism shifts in 
different stages of gingivitis. In the first 2 days, the tissue demonstrated increased rods and cocci 
bacterial species followed by fusebacteria and filamentous bacteria in days 2-4 of disease 
development. In the 4th day and beyond vibrios and spirochetes appeared. Once the oral hygiene 
measures were resumed the microbial colonization shifted back to its normal flora demonstrating 
a reversible condition of gingivitis (Loe, Theilade et al. 1965). In another study spirochetes and 
flagellated bacteria were predominant in the subgingival plaque (Listgarten 1976). 
3.7.4. Chronic periodontitis  
A change in bacterial flora occurs as disease progresses from gingivitis to periodontitis. 
This is accompanied by the clinical manifestation of apical migration of the epithelial 
attachment. An increase in the inflammatory response occurs in the outer surface of the plaque. 
A “test-tube brush” or “bristle-brush” formation of bacteria is made of mostly flagellated 
microorganisms in subgingival plaque of periodontitis cases (Listgarten 1976). Increasing 
probing depth in sites that demonstrated disease progression was correlated with the presence of 
spirochetes (Listgarten and Levin 1981, Loesche, Syed et al. 1985). Diseased sites were mostly 
populated by gram-negative anaerobes, spirochetes and black-pigmented species such as P. 
gingivalis (Pg) and P.intermidia as opposed to healthy individuals (Loesche 2007). 
3.8. Association of P. gingivalis and Chronic Periodontitis  
Many studies have investigated the association of different bacteria with chronic 
periodontitis. A study by Di Murro et al (1997) examined and compared periodontitis, untreated 
gingivitis and treated gingivitis subjects for the presence of P. gingivalis, B. Forsythus, and T. 
denticola (Loesche, Bretz et al. 1990, Di Murro, Paolantonio et al. 1997). In all of three groups, 
prevalence of those bacteria was 100%. However, P. gingivalis was significantly different 
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between treated gingivitis and untreated gingivitis and treated gingivitis and periodontitis (Di 
Murro, Paolantonio et al. 1997). The presence of those bacteria are not indicative of the disease 
since they were isolated from treated gingivitis subjects with little signs of inflammation but their 
concentration is the determining factor for disease onset and progression (Di Murro, Paolantonio 
et al. 1997).  
P. gingivalis was among those bacteria isolated form deeper pockets and more attachment 
loss (Takeuchi, Umeda et al. 2001). It has been identified as a major etiological agent of chronic 
periodontitis (Slots and Ting 1999).  
3.9. Description of P. gingivalis  
P. gingivalis is a gram-negative, non-motile, rod-shaped anaerobic bacterium. Its virulence 
factors includes: bacterial Lipopolysaccharide (LPS), Gingipains, Fimbriea (fimA) which are 
contributing factors in activation of immune response (Bodet, Chandad et al. 2005) and in turn 
results in tissue destruction. 
3.9.1. Lipopolysaccharide (LPS) 
Gram negative bacteria have unique structures particularly in the envelope. This envelope is 
composed of outer and inner membranes each of which consists of two layers of lipid. 
Phospholipid is the major components of both lipid bilayers of the inner membrane. The inner 
side of the outer membrane is composed of phospholipid and lipid A forms the outer part of the 
outer membrane lipid bilayer (Jain and Darveau 2010).  
Lipopolysaccharide (LPS) forms the outer surface of gram negative bacteria. It is composed 
of a polysaccharide side chain O-antigen on the external surface of the bacterium, attached to the 
core Lipid A and a short core of oligosaccharides (Osborn 1963, Nikaido and Vaara 1985, Raetz 
and Whitfield 2002). The bacterial strains can be differentiated from each other since the O-
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antigen is variable. It has the ability to induce a strong immune response (Jain and Darveau 
2010). In addition Lipid A is the bioactive part of the polysaccharide known as endotoxin and 
has the ability to induce the innate immune response (Loppnow, Durrbaum et al. 1990). The 
mechanism by which the LPS induces the immune response has been extensively studied. The 
immune system recognizes the general pattern of most bacteria through a complex structure 
known as Toll-like receptor 4 (TLR4), MD-2 and CD14. This complex contains a specific 
binding protein that plays an important role in the recognition of LPS. This complex is found on 
the surface of cells such as macrophages and dendritic cells (Schumann, Leong et al. 1990, 
Wright, Ramos et al. 1990, Poltorak, He et al. 1998, Hoshino, Takeuchi et al. 1999, Qureshi, 
Lariviere et al. 1999, Shimazu, Akashi et al. 1999). Once the Toll-like receptor 4 complex 
recognizes and binds to LPS it stimulates several cascades that end with macrophage activation 
(Akira and Takeda 2004) which causes the release of  pro-inflammatory cytokines such as tumor 
necrosis factor-alpha (TNF-σ), interleukin-beta (IL-1β), interleukin-6 (IL-6) and interleukin-8 
(IL-8) (Takeuchi and Akira 2001, Doyle and O'Neill 2006). If this response is overactive or 
uncontrolled it will lead to destruction of the tissue and causes disease.  
Although enteric bacteria such as E. coli lipid A is considered to be a potent agonist for 
innate immunity, P. gingivalis lipid A induces a weaker immunogenic response (Mansheim, 
Onderdonk et al. 1978, Fujiwara, Ogawa et al. 1990, Ogawa, Uchida et al. 1994, Darveau, 
Cunningham et al. 1995, Ogawa and Uchida 1996). It was also found to possess great 
heterogeneity in the lipid A structure (Ogawa 1993, Kumada, Haishima et al. 1995, Darveau, 
Pham et al. 2004, Rangarajan, Aduse-Opoku et al. 2008, Coats, Jones et al. 2009). The different 
structures causes different immune responses that vary between agonist, antagonist or having no 
effect on the toll-like receptor 4 (Jain and Darveau 2010). One of the factors that contributes to 
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this heterogeneity is the availability of hemin (Olczak, Simpson et al. 2005). Hemin provides P. 
gingivalis with iron that is essential for its growth (Jain and Darveau 2010). During periodontal 
inflammation the increased blood supply to the infected area provides a source of iron for the P. 
gingivalis residing in the the periodontal tissue that leads to more growth and eventually 
increasing its virulence (Marsh, McDermid et al. 1994, Olczak, Simpson et al. 2005). 
Bodet et al (2010) studied the effect of LPS from red complex bacteria or LPS of each 
bacterial strain cultured alone on epithelial cells and macrophages (Bodet, Chandad et al. 2006). 
Co-culture of the red complex bacterial LPS or culturing each alone did not significantly 
stimulate pro-inflammatory mediators such as IL-1 ß, TNF-σ and IL-6 secretion (Bodet, 
Chandad et al. 2006). All red complex bacterial LPS stimulated the secretion of IL-8 as well as 
MMP-9 whether were cultured together or alone (Bodet, Chandad et al. 2006). MMPs are 
important enzymes that are involved in connective tissue remodeling. It might cause significant 
destruction of the periodontal tissue leading to periodontal disease (Bodet, Chandad et al. 2006). 
P. gingivalis media stimulated the secretion of prostaglandin E2 (PGE2) which is a strong bone 
resorption inducer (Raisz, Pilbeam et al. 1993) and has been associated with attachment loss 
(Offenbacher, Odle et al. 1984). LPS also causes an increase in pro-inflammatory cytokines, 
induces bone resorption and interferes with osteoblastic differentiation (Kadono, Kido et al. 
1999). The induction of bone resorption induced by LPS was found to be attributed to its 
potential to up-regulate RANKL and PGE2 and to down regulate OPG (Reddi, Bostanci et al. 
2008) which are important signaling pathways in the differentiation of osteoclasts and in turn 
bone loss.  
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3.9.2. Gingipains 
Arg- and Lys-gingipains are cysteine proteinases known for their proteolytic activity 
(Kuramitsu 1998, Lamont and Jenkinson 1998, Curtis, Kuramitsu et al. 1999) They are virulence 
factors for P. gingivalis. They can be cell-bound or secreted by P.gingivalis  (Travis, Pike et al. 
1997, Kadowaki, Nakayama et al. 2000). Through these proteases P. gingivalis is able to 
colonize the host, affect the immune system and cause tissue destruction (Kuramitsu 1998, 
Lamont and Jenkinson 1998, Holt, Kesavalu et al. 1999). They also provide the bacteria with 
nutrition through digesting the host protein to obtain amino acids needed by the bacteria 
(Gharbia and Shah 1991, Shah and Gharbia. 1993 ). These proteases were found in the 
periodontal sites in periodontitis patients and may act as an antigen (Ismaiel, Greenman et al. 
1988, Genco, Potempa et al. 1999). Brochu et al (2001) found that Lys-gingipain, a type of 
protease, plays a role in providing P. gingivalis with iron delivered from human transferrin 
(Brochu, Grenier et al. 2001). Human serum albumin acts as a source of carbon and nitrogen 
needed for the growth of P. gingivalis. Arg-gingipain also plays a role in this process (Grenier, 
Imbeault et al. 2001).  
Tissue damage resulted from gingipain has been reported. Gingipains can degrade 
fibronectin and collagen of the extracellular matrix (Smalley, Birss et al. 1988, Scragg, Cannon 
et al. 1999). Moreover, they have the ability to stimulate the host matrix metalloproteinases 
(MMPs) (DeCarlo, Windsor et al. 1997) and inhibit proteinase inhibitors (Grenier 1996, Grenier 
and Mayrand 2001) which contribute to the pathogenesis of tissue destruction in periodontitis. It 
also modulates the immune system through induction of secretion of pro-inflammatory cytokines 
such as IL-1, IL-6, IL-8 and TNF-σ which will lead to tissue damage and bone resorption 
(Calkins, Platt et al. 1998, Banbula, Bugno et al. 1999). 
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3.9.3. Fimbriae 
Fimbriae are found on the surface of P. gingivalis and have the shape of filaments. They 
serve as appendages and are important for attachment of the bacteria. P. gingivalis possess six 
different types of fimbriae (fimA) (I to V and Ib) with each having different pathogenicity. Type 
II fimbA was found to be most associated with periodontitis followed by type IV fimA whereas 
periodontal healthy subjects have Type I fimbA (Amano, Nakagawa et al. 2004, van der Ploeg, 
Giertsen et al. 2004). The role of fimbA in periodontitis seems to be on its effect on immune 
system cytokines. Significant stimulation of pro-inflammatory cytokines such as IL-1B, IL-8, IL-
12 and TNF-σ mRNA in the U937 macrophages-like human cells has been reported by type II 
fmbA (Sugano, Ikeda et al. 2004). This was confirmed in another study (Bodet, Chandad et al. 
2006). The P. gingivalis strain that produces type II fimbA is the most potent strain of all other 
stains (Bodet, Chandad et al. 2006).  
3.9.4. Kavain  
Kavain is a natural compound extracted from plant known as methysticm Forst, one of the 
pepper plant family (Meyer and Kretzschmar 1966). This plant grows throughout the pacific 
countries (Pepping 1999). It is used recreationally by extracting the kava and using it in water 
beverages (Brunton 1988, Singh 1992, Balick and Lee 2002, Rychetnik and Madronio 2011) 
Kavain has CNS effects (Kretschmar and Meyer 1969) and has a verity of uses that are widely 
distributed through Pacific medicine. These uses includes aesthesia, sedation, relaxant, relief of 
headaches and anti-inflammatory effects (Singh 1992, Pepping 1999, Gounder 2006, Rowe, 
Zhang et al. 2011). Heavy and chronic use of Kava extracts results in symptoms including 
reddening of the eyes, liver toxicity, degradation of the skeletal muscle (Kava 2001, Brown, 
Onopa et al. 2007, Fu, Xia et al. 2008, Lude, Torok et al. 2008, Rowe, Zhang et al. 2011, 
20 
	
Teschke, Sarris et al. 2012). and scaling of the dermis layer of the skin (Norton and Ruze 1994, 
Guro-Razuman, Anand et al. 1999, Grace 2005, Fu, Xia et al. 2008).  
It is agreed now that periodontal tissue damage results from host immune response to 
bacterial challenge. It depends on the concentration of activated pro-inflammatory cytokines 
such as IL-1, -6, -11, -17 and TNF-α (Yuan, Gupte et al. 2011). TNF-α  is one of the mediators 
produced by monocytes and macrophages (Tang, Fenton et al. 2003) that increase recruitment of 
neutrophils and macrophages to the site of infection (Banno, Gazel et al. 2004). The  
RANK/RANKL/OPG signaling pathway is involved in bone resorption and results from 
inflammatory process in periodontal disease (Yuan, Gupte et al. 2011). By preventing the release 
of TNF-α, the inflammatory process could be controlled and destruction of periodontal tissue, 
including bone, can be reduced or prevented. Soluble receptors to TNF (TNFR-Fc) and IL-1 (IL-
1R-Fc) have reduced the inflammation and bone loss in experimental periodontitis (Assuma, 
Oates et al. 1998, Zhang, Kohli et al. 2004). Yuan (2011) investigated the effect of Kavain in P. 
gingivalis-induced periodontitis model on bone loss, epithelial downgrowth, inflammatory cell 
counts and expression of pro-inflammatory mediators. Kavain has the potential to reduce bone 
loss, epithelial downgrowth and inflammatory cells counts of polymorphnuclear leukocytes and 
macrophages. Furthermore, Kavain reduced the expression of cytokines particularly at day 7 
(Yuan, Gupte et al. 2011). In another study by Tang and Amer, LPS-induced TNF-α secretion 
was reduced by Kavain. Kavain was effective against mouse macrophages, mouse bone marrow 
macrophages and human peripheral blood mononuclear cells (Tang and Amar 2016).  
 
4. Aim and Goals  
 The pathogenesis of bone loss in chronic periodontitis cases are not fully understood (Iino 
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and Hopps 1984). There have been several in vitro and in vivo studies have been conducted 
investigating the different aspect of the pathogenesis of chronic periodontitis. In our study, we 
have chosen to use mouse calvarial model which provides a live bone organ system with 
multicellular composition capable of responding to external stimuli and added factors that make 
it more advantages over other previously used models. We aimed to examine the effect of P. 
gingivalis supernatant on mouse calvaria bone metabolism to further investigate the mechanism 
behind bone resorption in periodontitis associated with P. gingivalis bacterium. Furthermore, we 
hypothesized that LPS is the virulence factor causing bone loss and to rule out any other factors 
Kavain was used to inhibit the LPS and evaluate the effect on bone biology. 
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5. Materials and Methods 
5.1. Mouse calvaria organ cultures:    
Calvaria from 5-7 day old CD-1 mice (Charles River Laboratories, MA) were dissected 
under sterile conditions. Calvaria were cut in the occipital lobe, and partially in the frontal lobe, 
to produce a trapezoid shape and were then washed briefly in culture medium.  
The bone organ culture medium consisted of Dulbecco’s modified Eagle medium (DMEM) 
supplemented with bovine serum albumin (BSA), 100U/ml penicillin, 100µg/ml streptomycin 
and 250 ng/ml amphotericin B (Gibco, Grand Island, NY) without fetal calf serum (FCS) or 
ascorbate.  
Five groups of calvarial bone organ cultures were established as follows: group (1) 
unstimulated control (5 calvaria); group (2) bone resorption model stimulated by parathyroid 
hormone (PTH, 6 calvaria) (80 µL of PTH with a concentration of 10 nM in 50 ml of DMEM-
BSA); group (3) Bone resorption model (6 calvaria) stimulated by PTH and supplemented with 
Kavain (80 µL of PTH with a concentration of 10 nM in 50 ml of DMEM-BSA with 300µL of 
diluted Kavian 100 µg/ml ); group (4)  Porphyromonas gingivalis culture media (Pg media) ( 25 
ml of Pg culture media in 100 ml of DMEM-BSA to give 25% concentration of Pg media) and 
group (5) Porphyromonas gingivalis culture media (6 calvaria) ( 25 ml of Pg culture media in 
100 ml of DMEM-BSA to have 25% concentration of Pg media) supplemented with Kavain 
(300µL of diluted Kavian 100 µg/ml ).  
The bone resorption group containing PTH stimulates differentiation of osteoclasts and 
bone resorption. The control group with no stimulation for osteoclast activity allows comparison 
of biological activity in the other groups where PTH was used to stimulate osteoclast 
differentiation.  
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The P. gingivalis medium was made using P. gingivalis strain (33277). Supplemented 
tryptic soy broth was prepared according to the ATCC company instructions, autoclaved at 
121°C and the bottle was wrapped in aluminum foil. Comile minerals (6 ml) and 20 µL of P. 
gingivalis bacteria that had been stored at -80 °C were added to 20 ml of the prepared media. The 
culture was then incubated with constant movement for 3 days then frozen at -26 °C. The 
cultured P. gingivalis was centrifuged to separate the Pg from the culture media which was 
utilized for this experiment.  
The calvarial bone organ cultures were performed as described previously where calvaria 
were placed on stainless steel grids so that the bone was elevated and the medium formed a thin 
film over the bone surface (Goldhaber and Rabadjija 1987, Rabadjija, Brown et al. 1990). They 
were incubated at 37°C with 5% CO2 in a tissue culture incubator (NAPCO, Winchester,VA) for 
8 days. The media was changed every 2-3 days and the used media was frozen at -20°C for 
calcium assay and TRAP activity analysis.  
5.2. Determinations of osteoclast activity by Neutral Red stain 
Neutral Red stain was used to visualize multinucleated osteoclast activity since it is rapidly 
absorbed by multinucleated osteoclasts (Curtin, McHugh et al. 2009), Curtin et al 2012). At the 
end of experiment, 3 calvaria of each group were stained with Neutral red (NR, Sigma-Aldrich 
Co.) (70µg/ml in DMEM-BSA) and incubated for an hour at 37°C. This was followed by 
counterstaining with 2% silver nitrate (Sigma- Aldrich Co.) for 20 min in order to microscopically 
view the corresponding areas of bone resorption. 
For histological observation the remaining calvaria of each group were fixed in 10% formalin, 
decalcified, paraffin sectioned (5µm), and stained with hematoxylin and eosin (H&E, Boston 
Medical Center, Department of Pathology core facility).  
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All digital images of H&E stained sections were captured under 10X magnification with a 
compound microscope (Nikon), by Retiga 1330 digital camera (Qimaging, Canada).  
5.3. Assessment of media calcium released during bone resorption 
In our study bone resorption was reflected by calcium release into the media. The calcium 
assay was based on a chemical reaction resulting from a calcium chelating chromorphoric 
reagent reacting with calcium ion (Dorogi, 1984). The reaction forms an intense purple complex 
which is measured by absorbance that is directly proportional to the calcium concentration of the 
media.  
5.3.1. Determination of Standard Curve for Calcium Release Assay 
A standard curve was used to determine and calculate the media calcium concentration. 
Stock calcium chloride solution was made by weighing 1.8 mg O-Cresophthalein complex one 
(Sigma-Aldrrich Co.) reagent, and dissolved in 10 ml sodium bicarbonate buffer, pH 10.8 
(concentration =50 mM). Calcium chloride (CaCL2) standards with concentrations ranging from 
0-70 nmol/10µl were prepared. 10µl CaCL2 standards and 190 µl O-Cresolphthalein complex 
one reagent solution were loaded into 96 well plate and absorbance measured using Berthold 
Tristar LB 941 plate reader (Berthold Technologies GmbJ & Co. KG.) at wavelength of 590nm. 
Linearity of assay and correlation value greater than 0.98 were achieved. See figure (1).  
5.4. O-Cresolphthalein complex one Calcium Assay 
190 µl of calcium reagent were pipetted into a 96 well plate followed by addition of 10 µl of 
each standard and each sample into their respective wells. The assay was carried out in duplicate. 
The absorbance values were obtained with Berthold Tristar LB 941 (Berthold Technologies 
GmbJ & Co. KG.) at wavelength of 590nm.  
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 Average absorbance values were calculated for each standard and sample. Background 
reading was adjusted by subtracting averaged blank standard absorbance value from the average 
sample absorbance values. Average standard absorbance values were plotted as a function of 
final calcium concentration to obtain the standard curve equation of y =mx. Corrected sample 
absorbance values were plotted to calculate the final calcium concentration. Sample dilution 
factor was taken into account by multiplying the final calcium concentration by 0.1 to obtain 
units of µm/ ml. The data reflect calcium release or uptake for each collection time point. Using 
Microsoft Excel the data were plotted as a function of time and cumulative calcium release or 
uptake graphs.  
5.5. Assessment of osteoclast activity with TRAP  
TRAP is an enzyme expressed by osteoclasts during bone resorption and used as a marker for 
osteoclast activity. The TRAP assay utilizes the inhibitory effect of nitrate on non-TRAP to 
isolate the TRAP activity.  Osteoclast activity is determined utilizing p-nitrophenyphosphate (P-
NPP) as a chromogenic substrate in the assay. TRAP dephosphorylates p-NPP producing p-
nitrophenol (p-NP) which under alkaline condition deprotonates the phenolic (-OH) group 
producing a bright yellow color that can be measured by ultraviolet and visible light 
spectrophotometry.  
The TRAP reagent buffer, pH 4.8, consisted of 0.1 M Sodium Acetate ( C2H3NaO2), 50 mM 
Tartaric Acid (C4H6O6), 16 mM p-NPP (Sigma-Aldrich, Co), 1 mM Zinc Chloride (ZnCL2). The 
assay was carried out in duplicate and TRAP activity was measured by incubating 50 µl of each 
sample medium with 250 µl of the TRAP reagent buffer in each well of a 96 well plate for 30 
minutes at 37°C. At the end of the incubation time 10 µl of 1M NaOH was added to each well to 
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stop the reaction and absorbance measured at a wavelength of 405 nm using Beckman 
spectrophotometer  (Curtin et al 2012).  
5.6. TRAP Calculation 
The absorbance measurement for TRAP assay were calculated by subtracting the average 
background absorbance. Concentration of p-NP was calculated with adjusted measured 
absorbance using Beer-Lambert law equation, c = Aλ/ (ΣλX I). Using the molar absorptivity 
constant (Σ405) of 12,500 (mol/L)-1cm-1 and a path length (1) of 1cm. Incubation time of  3 hours 
was used to calculate the rate of substrate hydrolysis in units of mol/L*min. The final enzyme 
activity is expressed in unit of µMol/L*min.  
5.7. Statistical analysis 
Data are presented as means ±SD. The significance of differences between groups was 
determined using two-tailed, paired t test with unequal variance. The differences between groups 
were considered statistically significant for P<0.05.  
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Figure 1- example of Actual Standard Curve Used. Experimental standard curve plotted after 
background correction to be used in the calculation of calcium concentration. The absorbance 
value was obtained with Berthold Tristar LB 941 plate reader (Berthold Technologies GmbJ & 
Co. KG) at wavelength of 590 nm. 	
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6. Results  
6.1. Cumulative Calcium Release 
Total cumulative calcium release and TRAP activity for each experimental group over the 
eight days culture period are represented in Figure (2).  
Figure (2) shows calcium released in the collected media from calvaria of control group, 
Parathyroid hormone (PTH) group, P. gingivalis supernatant group (Pg), PTH co-cultured with 
Kavain (D) (PTH+D) and P. gingivalis supernatant co-cultured with Kavain (Pg+D). A 
comparison between control calvaria and PTH treated calvaria showed significantly increased 
calcium release indicating extensive bone resorption in PTH group which serves as effective 
positive control group for this experiment. Comparison between PTH calvaria and PTH calvaria 
co-cultured with Kavain demonstrated significant decrease in the calcium release reflecting the 
inhibitory effect of Kavain on PTH-induced bone resorption. In addition, there was no difference 
between control calvaria when compared to PTH calvaria co-cultured with Kavain, indicating 
that Kavain produced a significant inhibition on PTH effect. Comparison of P. gingivalis 
supernatant calvaria and PTH calvaria showed a significantly reduced calcium release in the P. 
gingivalis supernatant group. Although there was a huge reduction in calcium release when P. 
gingivalis supernatant co-cultured with Kavain in relation to P. gingivalis calvaria cultured 
alone, the difference was not significant. However, comparison between PTH calvaria co-
cultured with Kavain was significantly higher than P. gingivalis calvaria co-cultured with 
Kavain.  
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Figure 2- Cumulative Calcium Changes in Resorption Model.  A comparison of the calcium 
release over eight days experiment showed the highest release was among the Parathyroid 
hormone (PTH) group and was significantly higher than the control group and the P. gingivalis 
(Pg) group that showed some calcium uptake rather than release. When Kavain (D) was added to 
the PTH and Pg group, there was significant decrease in calcium release in PTH and further 
calcium uptake in Pg group. 	  
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6.2. TRAP Activity 
TRAP activity was correlated with the cumulative calcium release in each experimental 
group as shown in Figure (3). There was a significant increase in TRAP activity between control 
calvaria and PTH treated calvaria which was significantly decreased when Kavain was co-
cultured with PTH. However, the difference between PTH treated calvaria and PTH treated 
calvaria co-cultured with Kavain was significantly less indicating the inhibitory effect of Kavain 
on PTH-induced osteoclastic activity and bone resorption. Those former mentioned groups were 
correlated with the cumulative calcium release as discussed earlier. The striking finding is this 
was the case when TRAP activity was analyzed for P. gingivalis calvaria group and P. gingivalis 
calvaria co-cultured with Kavian where there was significantly less calcium release despite the 
tremendous amount of TRAP activity measured in those two groups. There was significant 
difference between the P. gingivalis supernatant group and P. gingivalis supernatant co-cultured 
with Kavain when they been compared to the other groups, however, there was no difference 
when compared to each other. 
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Figure 3- TRAP Activity. TRAP activity was significantly higher in Parathyroid group (PTH) 
in comparison to control group, however, when Kavain (D) was added to the PTH, the TRAP 
activity decreased to a level that it is not significantly different than control. P. gingivalis (Pg) 
and Pg with Kavain (Pg+D) both demonstrated high TRAP activity and were not significantly 
different however, they were significantly higher than other groups.  
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6.3. Cumulative Release Vs Time  
Calcium released into the calvaria media over the 8 days of the experiment was measured 
Figure (4). Figure (4) represents the net calcium release after being adjusted according to the 
calibration curve and correlated with time for those groups: control calvaria, PTH calvaria, PTH 
co-cultured with Kavain, P. gingivalis supernatant calvaria and P. gingivalis supernatant calvaria 
co-cultured with Kavain. In control calvaria the calcium release was highest in the first two days 
and reached a plateau after the fourth day. The PTH treated calvaria calcium release was the 
highest of all groups and gradually decreased over time. Combining PTH with Kavain 
significantly reduced the calcium release. On day 8 calcium release reached a point close to the 
lowest calcium release by the PTH group. Moreover, in the P.gingivalis group calcium release at 
day 2 was not different from the control group but was significantly reduced over time. The 
reduction on calcium release peaked on day 4 and then continued in a plateau. Similar to PTH 
calvaria co-cultured with Kavain, P. gingivalis supernatant calvaria co-cultured with Kavain 
showed significant reduction of calcium release compared to the control group and lower then P. 
gingivalis supernatant calvaria cultured alone. The reduction peaked on day 4 then increased to 
the level of P. gingivalis supernatant alone on day 6 and continued in a plateau. Addition of 
Kavain to either PTH calvaria group or P. gingivalis supernatant calvaria group reduced the 
release of calcium to half the amount produced by those groups alone. However, both groups 
with or without Kavian reached similar calcium release by the end of the experiment.  
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Figure 4- Calcium Release Over Time. A comparison of calcium release over time with 2 days 
interval was examined. Calcium release was very high in Parathyroid hormone (PTH) group and 
was decreasing in every two days interval. When Kavain (D) was added to the PTH group 
(PTH+D), calcium release was similar in the first two days to the control group but significantly 
less than the PTH alone and continued to be low in the rest of the experiment. P. gingivalis (Pg) 
group calcium release was similar to control group in the first two days then decreased and 
changed to calcium uptake rather than release to the rest of the experiment. Adding Kavain to Pg 
(Pg+D) prevented the calcium release that was observed in the first two days and continued to 
rest of the experiment time.  
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6.4. Histologic observation of osteoclastic activity by neutral red staining and 
observation of corresponding resorption through silver nitrate staining 
Calvaria sections stained with neutral red and silver nitrate stains are illustrated in figure (5). 
Figure (5) (Control) had few osteoclastic cells and no bone resorption in the corresponding silver 
nitrate section. However, multiple sites of osteoclastic activity were observed in Figure (5) (PTH 
alone) with clear bone resorption seen in corresponding silver nitrate stained section. When 
Kavain was added to the PTH calvaria the osteoclastic activity was inactivated or reduced figure 
(5) (PTH + K). Macrophages were present that did not develop into osteoclasts and therefore 
there was no bone resorption. In figure (5) ( Pg alone) and Figure (5) (Pg with K), few 
macrophages were observed with no developed osteoclastic cells as well as no bone resorption.  
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Figure 5- NR and SN Histological sections. Neutral Red on the left and Silver Nitrate on the 
right. Neutral red samples (Right) with 10X/0.25 magnification (Above) and 40X/0.65 
magnification (Below) showing some osteoclast cells in the Parathyroid hormone (PTH) group 
where P. gingivalis (Pg) and Pg with Kavian (Pg+D) showed only some Macrophages that failed 
to differentiate into Osteoclast cells. Silver nitrate samples (Left) with 10X/0.25 maginification 
showed corresponding resorption in the PTH group and absence of resorption area on the other 
groups.  
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6.5. Histologic observation by H & E stain 
Calvaria sections stained with neutral red and silver nitrate stains are illustrated in figure 6. In 
figure (6) (Control), bone can be seen clearly with no resorption areas whereas in PTH group 
figure (6) (PTH) there was area of bone resorption and discontinuation. In the rest of the groups, 
figure (6) ( PTH+K, Pg, Pg+K) bone was available with no signs of resorptions.  
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Figure 6- H&E Histological sections. 10X/0.25 magnification (Right) and 40X/0.65 
magnification (Left). Evidence of bone resorption can be seen only in the Parathyroid group 
(PTH) where it was absent in the other groups.  
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7. Discussion  
P. gingivalis is an anaerobic black-pigmented bacterium that is one of the red complex bacteria 
associated with chronic periodontitis. It has several mechanisms and virulence factors through 
which it invades the periodontium. Virulence factors includes Lipopolysaccharide (LPS), 
gingipain, and fimbriae all of which allow the bacteria to attach to the host cells. Cells then 
internalize the bacteria which induces release of inflammatory mediators and activates the 
immune system and yet the bacteria escape immune defenses and survive.  
Several studies have been conducted to understand the mechanism of chronic 
periodontitis as a result of P. gingivalis infection.  However, the mechanism for induction of 
bone resorption is still unclear.  
We hypothesized that P. gingivalis supernatant can induce bone resorption and that was 
compared with Parathyroid hormone (PTH)-induced bone resorption. This is based on previous 
studies showing that LPS and other P. gingivalis virulence factors can induce inflammation and 
release of cytokines including TNF-α that stimulates bone resorption. We used a unique mouse 
calvarial bone organ cultures that provides a similar microenvironment to in vivo bone with its 
multicellular activity and responses. Bone resorption was indicated by calcium release and 
TRAP activity that correlates with the activity of osteoclasts combined with neutral red staining 
that stains the live multinucleated cells and silver nitrate to show the corresponding bone 
resorption areas. Histological sections stained with H&E provided additional information of the 
cellular activity.  
We found that P. gingivalis supernatant caused less calcium release than PTH. In fact, 
there was calcium reuptake as demonstrated in Fig (2). TRAP activity was significantly higher 
than in PTH treated calvaria which did not correspond with the P. gingivalis supernatant calcium 
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release. In addition, multinucleated cells were clearly seen in the PTH-induced calvaria stained 
with neutral red indicating differentiation of osteoclasts whereas in P. gingivalis supernatant 
calvaria only macrophages were seen. This demonstrated an immune response but failure of 
macrophages to aggregate and differentiate to osteoclasts. That corresponded with the silver 
nitrate stained samples that showed large areas of bone resorption with PTH and less in P. 
gingivalis supernatant.  
This might be explained by several possible mechanisms. Possible explanation is that the 
dose of the P. gingivalis supernatant was not enough to induce osteoclast differentiation and 
bone resorption. In a study by Iino and Hopps, where they studied that effect of P. gingivalis 
LPS on calvaria live bone culture, they have found that calcium release as a results of bone 
resorption has been seen with purified LPS of P. gingivalis, however that was dose dependent 
with maximum dose of 10 µg/ml of LPS concentration and that activity decreases with increased 
concentration which might explain partially the calcium reuptake rather than release in the P. 
gingivalis supernatant sample confirming the dose-dependent activity fashion (Iino and Hopps 
1984).  Moreover, other explanation of our results is that bone was necrotic as a result of P. 
gingivalis infection leading lack of ability to have osteoclast differentiation.  
In chronic periodontitis, gingival tissue is heavily infiltrated with inflammatory cells, one 
of which is macrophages (Moskow and Polson 1991). Macrophages is one of the innate 
immunity cells that responds to infection. Activation of those macrophages has been linked to 
binding of LPS produced by bacteria to the Toll-like receptors found on macrophages surface 
(Akira and Takeda 2004). In one study, LPS effect on maturation and polarization of 
macrophages and its production of cytokines has been investigated (Holden, Attard et al. 2014). 
It was found that P. gingivalis LPS does not caue maturation of macrophages to osteoclasts 
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however, it was able to induce significant cytokines production despite its low dose (Holden, 
Attard et al. 2014). This might explain the highly infiltrated calvaria by macrophages in the P. 
gingivalis supernatants sample but failed to differentiate to osteoclasts or, at another level, 
induce few osteoclastic differentiation. The production of cytokines and chemokines by those 
cells that contribute to recruitments of other inflammatory cells but failure to increase or induce 
surface marker expression by P. gingivalis LPS might indicate that P. gingivalis modulate the 
immune system in a way and preventing pathogen clearance by those cells simultaneously 
leading to a state of chronic infection and inflammation (Tam, Brien-Simpson et al. 2009) 
(O'Brien-Simpson, Pathirana et al. 2009). 
When calcium release has been studied over time period, we found that PTH-induced 
calvaria sample indicated significant calcium release to start with but decrease gradually over 
time but was still higher than control group at day 8. On the other hand, in P. gingivalis 
supernatant calvaria sample, we have found that the peak of calcium reuptake was in the first 2 
days then reached a plateau till the end of the experiment at 8 day indicating no calcium release 
throughout the experiment period. Fig (4). In a study by Zhang et al they found that P. gingivalis 
was able to affect the mineralization process by osteoblasts and lower it over time. They found 
that both infected or uninfected osteoblasts cells deposited mineral with time but was only 
significantly lower than the control at day 14, 21 and 28 (Zhang, Swearingen et al. 2010) . 
However, it is important to note that in their study, they have used the bacterial cells rather than 
its supernatant only and the period of their experiment was longer than our study experiment.  
Bone formation/resorption process is controlled by RANKL/RANK/OPG signaling 
pathway. RANKL is ligand from tumor necrosis factor ligand family and it plays a role in 
osteoclasts differentiation and activation when it bound to RANK receptor found on osteoclasts 
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precursors (Wong, Rho et al. 1997, Lacey, Timms et al. 1998, Yasuda, Shima et al. 1998, Kong, 
Yoshida et al. 1999). OPG is an inhibitor of RANKL which will help to control the 
differentiation and activation of osteoclasts and maintain the homeostasis (Simonet, Lacey et al. 
1997, Yasuda, Shima et al. 1998). Many hormones have demonstrated the ability to stimulate the 
expression of RANKL such as PTH, 1,25-dihydroxy vitamin D3, and prostaglandin E2 (PGE2) 
as well as cytokines such as TNF-α, Interlukin-1ß and interleukin -6 (Nakashima, Kobayashi et 
al. 2000). In addition, it is proposed that P. gingivalis LPS can indirectly induce the RANKL and 
downregulate OPG in bone marrow stromal cells by increase the expression and function of 
PGE2 (Reddi, Bostanci et al. 2008). Also, LPS can stimulate the release of TNF-α and other 
cytokines from activated inflammatory cells (Takeuchi and Akira 2001, Doyle and O'Neill 2006) 
which if become overactive or uncontrolled, it will lead to destruction of the tissue and turn the 
condition into a pathological disease.  
To further study whether the effect of P. gingivalis supernatant on bone is resulted from 
LPS or other virulence factors, Kavain has been added to P. gingivalis supernatant and compared 
with positive control group of PTH with Kavain. Kavain has been chosen because it was reported 
to inhibit the production of TNF-α induced by bacterial LPS (Tang and Amar 2016, Tang and 
Amar 2016).  
In our study, we found that when Kavain has been added to PTH calvaria sample, there 
was reduction of calcium release to almost half of that of PTH calvaria alone. In P. gingivalis 
supernatant calvaria sample combined with Kavain, the calcium uptake has been increased 
almost to double that of P. gingivalis supernatant calvaria alone sample. Corresponding to it, 
TRAP activity showed reduction in both PTH and P. gingivalis supernatant sample when Kavain 
was added to both. However, the reduction of TRAP activity when Kavain was added to P. 
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gingivalis supernatant was not significantly different than that of P. gingivalis supernatant alone 
which was not the case of PTH with Kavain where there was significant reduction of TRAP 
activity as compared to PTH alone. The reduction of calcium release in PTH calvaria where 
Kavain was combined might indicate the Kavain has direct effect on osteoblasts where it induces 
its mineralization process increasing calcium uptake and thus reducing the effect of PTH 
resorption activity. Another explanation is that it inhibits RANKL signaling pathway induced by 
PTH thus favoring OPG activity and bone formation. This also can explain the calcium reuptake 
increase in P. gingivalis supernatant calvaria when combined with Kavain. Since Kavain can 
inhibit the LPS-induced TNF-α and thus reduce the inflammatory process and bone resorption. 
This was confirmed with neutral red and silver nitrate staining that showed no multinucleated 
cells have been identified in either PTH or P. gingivalis supernatant calvaria sample when 
combined with Kavain and no bone resorption could be seen on either as well. Also, these results 
indicate that LPS is one of the major contributors of P. gingivalis effect on bone and that Kavain 
could be possible line of treatment in near future for inhibition of P. gingivalis activity and thus 
possible treatment of chronic periodontitis.  
Our study suggests that P. gingivalis supernatant stimulate the inflammatory cells and the 
release of cytokines that might contribute to bone resorption and that LPS is the major 
contributor. However, long-term experimental study is needed to confirm these findings as well 
as studying of different dose and concentration of P. gingivalis supernatant should be 
implemented. Furthermore, it would be beneficial to study the effect of Kavain on the expression 
of RANKL and OPG and whether it favors bone formation or just block the bone resorption thus 
allowing bone formation to override.  
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